ShamsEldeen, Asmaa Mohammed <br/><br/>
Combined treatment with systemic resveratrol and resveratrol preconditioned mesenchymal stem cells, maximizes antifibrotic action in diabetic cardiomyopathy.  [electronic resource] 

 -  Journal of cellular physiology  07 2019 
 - 10942-10963 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-4652 
<br/><br/><label>Standard No.: </label>10.1002/jcp.27947  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antioxidants--therapeutic use<br/>Bone Malalignment<br/>Diabetes Mellitus, Experimental--complications<br/>Diabetic Cardiomyopathies--therapy<br/>Fibrosis--therapy<br/>Male<br/>Mesenchymal Stem Cell Transplantation<br/>Mesenchymal Stem Cells--drug effects<br/>Random Allocation<br/>Rats<br/>Rats, Wistar<br/>Resveratrol--therapeutic use